VIRTUAL: Clinical Trial Strategies in the Rare Neurodevelopmental Disorders: Challenges & Opportunities

Time: 12:00 pm
day: Day One: Track B AM


  • Summarizing latest thoughts on clinical trial approaches in RNDDs (including Angelman Syndrome, Dup15q Sydrome, Dravet syndrome, Rett Syndrome, Tuberous Sclerosis Complex, CDKL5-deficiency disorder and Fragile X Syndrome)
  • Sharing insights from both industry and academic perspectives on the future of translational medicine for the next generation of therapies in this field
  • Considering not only broader clinical trial design elements relevant to these populations but also of emerging commonalities and opportunities specific to RNDDs more broadly